Related references
Note: Only part of the references are listed.Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients
Yi Zhang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer
Lidong Wang et al.
ONCOTARGETS AND THERAPY (2019)
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
Tao Lu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS
Xinquan Wu et al.
ARCHIVES OF MEDICAL SCIENCE (2018)
Downregulation of microRNA-216b contributes to glioma cell growth and migration by promoting AEG-1-mediated signaling
Qi Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1
Yanfen Yao et al.
ONCOTARGETS AND THERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma
Yan Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1
Tingting Zhang et al.
ONCOLOGY REPORTS (2017)
Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
Gang Huang et al.
ONCOTARGET (2017)
microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo
Mengyao Sun et al.
CELL BIOLOGY INTERNATIONAL (2017)
MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis
Shanyang He et al.
BMC CANCER (2017)
miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP
Samir Jana et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Lung cancer and metastasis: new opportunities and challenges
Xiangdong Wang et al.
CANCER AND METASTASIS REVIEWS (2015)
Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Akhil Srivastava et al.
CURRENT GENE THERAPY (2015)
MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway
F-y Liu et al.
CELL DEATH & DISEASE (2015)
Upregulated IncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway
Feng Wang et al.
ONCOTARGET (2015)
Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer
Aneta Kowal et al.
THORACIC CANCER (2015)
miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
Min Deng et al.
JOURNAL OF CELL SCIENCE (2011)
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane et al.
CURRENT GENOMICS (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Lung cancer screening
JL Mulshine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications
J Niklinski et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2001)
Share Paper
